Literature DB >> 13083321

[Chemotherapy of myasthenia].

H BAUER, O SCHMID.   

Abstract

Entities:  

Keywords:  MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/therapeutic use

Mesh:

Substances:

Year:  1953        PMID: 13083321

Source DB:  PubMed          Journal:  Dtsch Z Nervenheilkd        ISSN: 0367-004X


× No keyword cloud information.
  10 in total

1.  Observations on the isolated phrenic nerve diaphragm preparation of the rat.

Authors:  E BULBRING
Journal:  Br J Pharmacol Chemother       Date:  1946-03

2.  Tubocurarine antagonism and inhibition of cholinesterases.

Authors:  H BLASCHKO; E BULBRING; T C CHOU
Journal:  Br J Pharmacol Chemother       Date:  1949-03

3.  Treatment of myasthenia gravis.

Authors:  C T STONE; J A RIDER
Journal:  J Am Med Assoc       Date:  1949-09-10

4.  [Not Available].

Authors:  F EICHHOLTZ; R HOTOVY; H ERDNISS
Journal:  Arch Int Pharmacodyn Ther       Date:  1949-07

5.  Present status of therapy in myasthenia gravis.

Authors:  N S SCHLEZINGER
Journal:  J Am Med Assoc       Date:  1952-02-16

6.  Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

Authors:  C H MILLIKAN; L M EATON
Journal:  Neurology       Date:  1951 Mar-Apr       Impact factor: 9.910

7.  Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.

Authors:  C TORDA; H G WOLFF
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-08

8.  Parasympathomimetic symptoms, sensitivity to acetylcholine and decurarization, in relation to inhibition of cholinesterases.

Authors:  H CASIER; R VERBEKE
Journal:  Arch Int Pharmacodyn Ther       Date:  1950-08-01

9.  The action of carbamic esters and tetraethylpyrophosphate on normal and curarized frog rectus muscle.

Authors:  F HOBBIGER
Journal:  Br J Pharmacol Chemother       Date:  1950-03

10.  [The effect of novocain (procaine) and diethylaminoethanol on the isolated phrenicus-diaphragma preparation of the rat].

Authors:  K SOEHRING; U STAVE
Journal:  Arch Int Pharmacodyn Ther       Date:  1951-02
  10 in total
  1 in total

1.  Mestinon (pyridostigmine bromide) in myasthenia gravis.

Authors:  H SCHWARZ
Journal:  Can Med Assoc J       Date:  1956-07-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.